Cytoreductive nephrectomy for metastatic renal cell carcinoma, the ultimate urologic ‘Choosing Wisely’ campaign: a narrative review

In the early 2000s, cytoreductive nephrectomy in addition to systemic cytokines became standard of care for treating metastatic renal cell carcinoma. Since that time, the development of novel systemic targeted therapies and immuno-oncologic agents have challenged the utility of cytoreductive nephrec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabakin, Alexandra L., Stein, Mark N., Anderson, Christopher B., Drake, Charles G., Singer, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751973/
https://www.ncbi.nlm.nih.gov/pubmed/33354523
http://dx.doi.org/10.21037/tcr-20-2343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751973/
https://www.ncbi.nlm.nih.gov/pubmed/33354523
http://dx.doi.org/10.21037/tcr-20-2343

Ejemplares similares